Fjarde Ap Fonden Jazz Pharmaceuticals PLC Transaction History

Fjarde Ap Fonden

$9.8 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$115.19 - $132.77 $1.69 Million - $1.95 Million	14,700 Added 36.52%	54,947 $6.62 Million
Q4 2023 Feb 14, 2024	BUY	$114.26 - $136.0 $525,596 - $625,600	4,600 Added 12.9%	40,247 $4.95 Million
Q3 2023 Oct 23, 2023	BUY	$122.0 - $145.31 $256,200 - $305,151	2,100 Added 6.26%	35,647 $4.61 Million
Q2 2023 Aug 02, 2023	SELL	$122.5 - $147.16 $845,250 - $1.02 Million	-6,900 Reduced 17.06%	33,547 $4.16 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $710,094 - $850,491	5,300 Added 15.08%	40,447 $5.92 Million
Q4 2022 Feb 14, 2023	BUY	$129.72 - $159.85 $700,488 - $863,190	5,400 Added 18.15%	35,147 $5.6 Million
Q2 2022 Aug 11, 2022	BUY	$141.59 - $168.66 $283,180 - $337,320	2,000 Added 7.21%	29,747 $4.64 Million
Q1 2022 May 13, 2022	SELL	$129.64 - $160.7 $648,199 - $803,500	-5,000 Reduced 15.27%	27,747 $4.32 Million
Q4 2021 Feb 15, 2022	SELL	$119.87 - $145.67 $503,454 - $611,814	-4,200 Reduced 11.37%	32,747 $4.17 Million
Q3 2021 Nov 15, 2021	BUY	$128.64 - $184.79 $488,831 - $702,202	3,800 Added 11.46%	36,947 $4.81 Million
Q2 2021 Aug 12, 2021	BUY	$160.2 - $186.42 $528,660 - $615,186	3,300 Added 11.06%	33,147 $5.89 Million
Q1 2021 May 17, 2021	BUY	$150.19 - $173.5 $991,254 - $1.15 Million	6,600 Added 28.39%	29,847 $4.91 Million
Q4 2020 Feb 12, 2021	BUY	$140.71 - $165.05 $211,065 - $247,575	1,500 Added 6.9%	23,247 $3.84 Million
Q3 2020 Nov 13, 2020	BUY	$105.46 - $144.13 $263,650 - $360,325	2,500 Added 12.99%	21,747 $3.1 Million
Q2 2020 Aug 13, 2020	BUY	$95.68 - $121.88 $9,568 - $12,188	100 Added 0.52%	19,247 $2.12 Million
Q1 2020 May 11, 2020	BUY	$87.74 - $152.74 $526,440 - $916,440	6,000 Added 45.64%	19,147 $1.91 Million
Q4 2019 Feb 10, 2020	BUY	$117.65 - $153.73 $929,435 - $1.21 Million	7,900 Added 150.56%	13,147 $1.96 Million
Q3 2019 Oct 31, 2019	SELL	$125.18 - $143.24 $103,649 - $118,602	-828 Reduced 13.63%	5,247 $672,000
Q2 2019 Jul 17, 2019	SELL	$125.55 - $144.48 $1.02 Million - $1.17 Million	-8,116 Reduced 57.19%	6,075 $866,000
Q1 2019 Apr 29, 2019	SELL	$121.81 - $142.95 $154,942 - $181,832	-1,272 Reduced 8.23%	14,191 $2.03 Million
Q4 2018 Jan 31, 2019	SELL	$115.94 - $166.74 $452,166 - $650,286	-3,900 Reduced 20.14%	15,463 $1.92 Million
Q3 2018 Nov 09, 2018	SELL	$161.01 - $180.57 $131,706 - $147,706	-818 Reduced 4.05%	19,363 $3.26 Million
Q2 2018 Jul 12, 2018	SELL	$146.33 - $183.18 $27,363 - $34,254	-187 Reduced 0.92%	20,181 $3.48 Million
Q1 2018 May 07, 2018	BUY	$135.59 - $157.16 $40,677 - $47,148	300 Added 1.49%	20,368 $3.08 Million
Q4 2017 Feb 12, 2018	BUY	$131.06 - $150.39 $314,412 - $360,785	2,399 Added 13.58%	20,068 $2.7 Million
Q3 2017 Nov 07, 2017	BUY	$142.62 - $155.6 $28,524 - $31,120	200 Added 1.14%	17,669 $2.58 Million
Q2 2017 Aug 08, 2017	BUY	N/A	17,469	17,469 $2.72 Million

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account